Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
480 22 |
Ultima descărcare din IBN: 2024-03-28 17:24 |
Căutarea după subiecte similare conform CZU |
616.98:578.834.1:616.61/68-06 (1) |
Boli transmisibile. Boli infecţionase şi contagioase, stări febrile (585) |
Virologie (445) |
SM ISO690:2012 DUMBRĂVEANU, Ion, BRADU, Andrei, ARIAN, Iurii, MUNTEANU (IVANOV), Mihaela, BULAI, Felicia, CEBAN, Emil. Impactul virusului SARS CoV-2 asupra sistemului urinar și reproductiv masculin. In: Revista de Ştiinţă, Inovare, Cultură şi Artă „Akademos”, 2021, nr. 3(62), pp. 41-48. ISSN 1857-0461. DOI: https://doi.org/10.52673/18570461.21.3-62.05 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista de Ştiinţă, Inovare, Cultură şi Artă „Akademos” | |||||||
Numărul 3(62) / 2021 / ISSN 1857-0461 /ISSNe 2587-3687 | |||||||
|
|||||||
DOI:https://doi.org/10.52673/18570461.21.3-62.05 | |||||||
CZU: 616.98:578.834.1:616.61/68-06 | |||||||
Pag. 41-48 | |||||||
|
|||||||
Descarcă PDF | |||||||
Rezumat | |||||||
SARS-CoV-2 virus affects all organs and systems of the human body, including urinary and reproductive. Covid-19 disease has symptoms, clinical evolution and unknown complications till our days. Based on urology-specific systematic literature review, the authors describe the epidemiology and mechanisms of male urinary and reproductive system damaged by SARS-CoV-2 virus. The pathogenesis of renal impairment in Covid-19 is multifactorial with direct action of the virus on the nephron, but especially due to factors generated by inflammatory process, intravascular coagulation, hypovolemia, cytokine storm or toxic drug action. The presence of kidney disease until infection with SARSCoV2 virus can be interpreted as a risk factor for the evolution of the disease. Covid-19 disease also has an impact on male sexual-reproductive function, due to erectile dysfunction, decreased sperm motility or hormonal influences. At the moment, there is no evidence about presence of the specific effective drug for the treatment of Covid-19, the only medical solution to avoid side effects of the disease, is and remains vaccination. |
|||||||
Cuvinte-cheie SARS-CoV-2 virus, COVID-19, kidney damage, male reproductive system, Virusul Sars CoV-2, COVID-19, afectare renală, sistem reproductiv masculin |
|||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-148648</cfResPublId> <cfResPublDate>2021-12-29</cfResPublDate> <cfVol>62</cfVol> <cfIssue>3</cfIssue> <cfStartPage>41</cfStartPage> <cfISSN>1857-0461</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/148648</cfURI> <cfTitle cfLangCode='RO' cfTrans='o'>Impactul virusului SARS CoV-2 asupra sistemului urinar și reproductiv masculin</cfTitle> <cfKeyw cfLangCode='RO' cfTrans='o'>SARS-CoV-2 virus; COVID-19; kidney damage; male reproductive system; Virusul Sars CoV-2; COVID-19; afectare renală; sistem reproductiv masculin</cfKeyw> <cfAbstr cfLangCode='EN' cfTrans='o'><p>SARS-CoV-2 virus affects all organs and systems of the human body, including urinary and reproductive. Covid-19 disease has symptoms, clinical evolution and unknown complications till our days. Based on urology-specific systematic literature review, the authors describe the epidemiology and mechanisms of male urinary and reproductive system damaged by SARS-CoV-2 virus. The pathogenesis of renal impairment in Covid-19 is multifactorial with direct action of the virus on the nephron, but especially due to factors generated by inflammatory process, intravascular coagulation, hypovolemia, cytokine storm or toxic drug action. The presence of kidney disease until infection with SARSCoV2 virus can be interpreted as a risk factor for the evolution of the disease. Covid-19 disease also has an impact on male sexual-reproductive function, due to erectile dysfunction, decreased sperm motility or hormonal influences. At the moment, there is no evidence about presence of the specific effective drug for the treatment of Covid-19, the only medical solution to avoid side effects of the disease, is and remains vaccination.</p></cfAbstr> <cfAbstr cfLangCode='RO' cfTrans='o'><p>Virusul Sars CoV-2 afectează toate organele și sistemele organismului uman, inclusiv urinar și reproductiv. Maladia Covid-19 are simptome, evoluție clinică și complicații necunoscute până acum. În baza analizei literaturii de specialitate autorii descriu epidemiologia și mecanismele afectării sistemului urinar și reproductiv masculin de către virusul Sars CoV-2. Patogenia afectării renale în Covid-19 este multifactorială, cu acțiune citopatică directă a virusului asupra nefronului, dar în special din cauza factorilor generați de procesul inflamator, coagularea intravasculară, hipovolemie, furtuna citokinică sau acțiunea toxică a medicamentelor. Prezența unor maladii renale până la infectarea cu virusul Sars CoV-2 poate fi interpretată drept un factor de risc al evoluției maladiei. Maladia Covid-19 are un impact negativ și asupra funcției sexual-reproductive masculine, prin apariția disfuncției erectile, scăderea motilității spermatozoizilor sau influențe hormonale. Întrucât până la ora actuală nu există un medicament specific eficient pentru tratamentul pacienților infectați cu noul coronavirus, unica soluție medicală de contracarare a efectelor maladiei este și rămâne vaccinarea.</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-11064</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-29881</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-53958</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-49211</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-52418</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-10919</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> </cfPers_ResPubl> <cfFedId> <cfFedIdId>ibn-doi-148648</cfFedIdId> <cfFedId>10.52673/18570461.21.3-62.05</cfFedId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> <cfFedId_Class> <cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId> <cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId> </cfFedId_Class> <cfFedId_Srv> <cfSrvId>5123451</cfSrvId> <cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId> </cfFedId_Srv> </cfFedId> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-11064</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11064-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> <cfFamilyNames>Думбрэвяну</cfFamilyNames> <cfFirstNames>И.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-29881</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-29881-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> <cfFamilyNames>Bradu</cfFamilyNames> <cfFirstNames>Andrei</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-53958</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-53958-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> <cfFamilyNames>Arian</cfFamilyNames> <cfFirstNames>Iurii</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-49211</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-49211-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> <cfFamilyNames>Munteanu (Ivanov)</cfFamilyNames> <cfFirstNames>Mihaela</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-52418</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-52418-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> <cfFamilyNames>Bulai</cfFamilyNames> <cfFirstNames>Felicia</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-10919</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-10919-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021-12-29T24:00:00</cfStartDate> <cfFamilyNames>Ceban</cfFamilyNames> <cfFirstNames>Emil</cfFirstNames> </cfPersName_Pers> </cfPers> <cfSrv> <cfSrvId>5123451</cfSrvId> <cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName> <cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr> <cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw> </cfSrv> </CERIF>